Home603233 • SHA
add
Dashenlin Pharmaceutical Group Co Ltd
Previous close
¥17.96
Day range
¥17.50 - ¥18.17
Year range
¥11.92 - ¥21.79
Market cap
20.45B CNY
Avg Volume
8.24M
P/E ratio
20.49
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 6.96B | 3.02% |
Operating expense | 1.74B | -1.37% |
Net income | 460.00M | 15.45% |
Net profit margin | 6.61 | 12.03% |
Earnings per share | — | — |
EBITDA | 1.09B | 9.78% |
Effective tax rate | 23.37% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.74B | 24.79% |
Total assets | 26.78B | 5.56% |
Total liabilities | 18.14B | 7.32% |
Total equity | 8.63B | — |
Shares outstanding | 1.14B | — |
Price to book | 2.78 | — |
Return on assets | 6.51% | — |
Return on capital | 11.05% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 460.00M | 15.45% |
Cash from operations | 1.77B | 44.14% |
Cash from investing | -119.96M | 73.89% |
Cash from financing | -880.84M | -306.94% |
Net change in cash | 767.04M | 39.30% |
Free cash flow | 952.54M | 115.90% |
About
Founded
Feb 12, 1999
Website
Employees
43,532